All In Biotech

Drug Trial Radar · NCT05587712

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

A Phase 2 Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept (MK-7962) in Children From 1 to Less Than 18 Years of Age With PAH on Standard of Care

Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

42

Planned (sponsor's estimate)

Start

Jan 19, 2023

Primary completion

Sep 21, 2028

Study completion Sep 21, 2028

Sponsor

Lead sponsor
Merck Sharp & Dohme LLCMerck & Co. (MRK)
Sponsor type
Industry
First posted
Oct 20, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 year, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to \<18 years of age with PAH World Health Organization (WHO) Group 1 on standard of care (SoC). There is no formal hypothesis.

Conditions

  • Pulmonary Arterial Hypertension

Interventions

  • SotaterceptDrug

    SC injection every 3 weeks (Q3W) of 0.3 mg/kg. Dosage may be adjusted based on protocol-specific guidelines.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serum Trough Concentration (Ctrough) of SotaterceptTime frame: Predose Day 1, Day 21, Day 42, Day 63, Day 84, Day105, Day 126, Day 147, Day 168, Day 189. Postdose Day 7, Day 14, Day 64, Day 69 and Day 76
  2. Area Under the Curve at Steady State (AUCss) of SotaterceptTime frame: Predose Day 1, Day 21, Day 42, Day 63, Day 84, Day105, Day 126, Day 147, Day 168, Day 189. Postdose Day 7, Day 14, Day 64, Day 69 and Day 76
  3. Area Under the Curve from 0 to 3 weeks (AUC0-3 weeks) of SotaterceptTime frame: Predose Day 1, Day 7, Day 14, and Predose Day 21
  4. Percentage of Participants Who Experience at Least 1 Adverse Event (AE)Time frame: Up to 24 weeks
  5. Percentage of Participants Who Discontinue Study Drug Due to an AETime frame: Up to 24 weeks
  6. Laboratory Parameter (Hematology): Concentration of HemoglobinTime frame: Up to 24 weeks
  7. Laboratory Parameter (Hematology): HematocritTime frame: Up to 24 weeks
  8. Laboratory Parameter (Hematology): Red Blood Cell (RBC) CountTime frame: Up to 24 weeks
  9. Laboratory Parameter (Hematology): Reticulocyte CountTime frame: Up to 24 weeks
  10. Laboratory Parameter (Hematology): Platelet CountTime frame: Up to 24 weeks
  11. Blood Pressure (BP)Time frame: Up to 24 weeks
  12. Titer of Anti-drug Antibody (ADA) to SotaterceptTime frame: Up to 24 weeks

Locations

35 sites in 12 countries. Site status is shown where the registry gives one.

  • The Regents of the University of California - Los Angeles (UCLA Pediatrics) ( Site 1606)

    Los Angeles, California · Recruiting

  • Stanford University School of Medicine ( Site 1603)

    Palo Alto, California · Recruiting

  • UCSF Benioff Children's Hospital San Francisco ( Site 1611)

    San Francisco, California · Recruiting

  • Children's Hospital Colorado ( Site 1609)

    Aurora, Colorado · Recruiting

  • Children's National Medical Center ( Site 1600)

    Washington D.C., District of Columbia · Recruiting

  • Cincinnati Children's Hospital Medical Center ( Site 1602)

    Cincinnati, Ohio · Recruiting

  • Children's Hospital of Philadelphia (CHOP) ( Site 1608)

    Philadelphia, Pennsylvania · Recruiting

  • Monroe Carell Jr. Children's Hospital ( Site 1601)

    Nashville, Tennessee · Completed

  • Seattle Children's Hospital ( Site 1605)

    Seattle, Washington · Recruiting

  • Children's Wisconsin ( Site 1610)

    Milwaukee, Wisconsin · Recruiting

  • The Children's Hospital at Westmead ( Site 0001)

    Westmead, New South Wales, Australia · Recruiting

  • Clinica Somer-Unidad de Investigacion y Docencia ( Site 0205)

    Rionegro, Antioquia, Colombia · Recruiting

  • Fundación Valle del Lili ( Site 0200)

    Cali, Valle del Cauca Department, Colombia · Recruiting

  • Clínica Imbanaco S.A.S ( Site 0203)

    Cali, Valle del Cauca Department, Colombia · Recruiting

  • Hôpital Universitaire Necker Enfants Malades ( Site 0300)

    Paris, France · Recruiting

  • CHU de Toulouse - Hôpital des Enfants ( Site 0302)

    Toulouse, Haute-Garonne, France · Recruiting

  • Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone ( Site 0303)

    Marseille, Provence-Alpes-Côte d'Azur Region, France · Recruiting

  • Universitaetsklinikum Heidelberg ( Site 0401)

    Heidelberg, Baden-Wurttemberg, Germany · Recruiting

  • Klinikum der Universität München Großhadern ( Site 0404)

    München, Bavaria, Germany · Recruiting

  • Medizinische Hochschule Hannover ( Site 0405)

    Hanover, Lower Saxony, Germany · Recruiting

  • Schneider Children's Medical Center ( Site 0603)

    Petah Tikva, Israel · Recruiting

  • Sheba Medical Center ( Site 0601)

    Ramat Gan, Israel · Recruiting

  • University Medical Center Groningen ( Site 0900)

    Groningen, Netherlands · Recruiting

  • Centrum Zdrowia Dziecka w Warszawie-Klinika Kardiologii ( Site 1103)

    Warsaw, Masovian Voivodeship, Poland · Recruiting

  • Uniwersyteckie Centrum Kliniczne-Klinika Kardiologii Dziecięcej i Wad Wrodzonych Serca ( Site 1102)

    Gdansk, Pomeranian Voivodeship, Poland · Recruiting

  • Wits Clinical Research-Chris Hani Baragwanath Hospital ( Site 1201)

    Johannesburg, Soweto, Gauteng, South Africa · Recruiting

  • Hospital Universitari Vall d'Hebron ( Site 1302)

    Barcelona, Spain · Recruiting

  • HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON ( Site 1301)

    Madrid, Spain · Recruiting

  • Hospital Universitario Ramón y Cajal ( Site 1300)

    Madrid, Madrid, Comunidad de, Spain · Recruiting

  • Hospital Universitari i Politecnic La Fe ( Site 1303)

    Valencia, Valencia, Spain · Recruiting

  • Hacettepe Universite Hastaneleri ( Site 1400)

    Ankara, Turkey (Türkiye) · Recruiting

  • Gazi University Health Research and Application Center Gazi -Çocuk Sağlığı ve Hastalıkları Anabilim ( Site 1402)

    Ankara, Turkey (Türkiye) · Recruiting

  • Ankara Bilkent Şehir Hastanesi. ( Site 1403)

    Ankara, Turkey (Türkiye) · Recruiting

  • Mehmet Akif Ersoy Research and Training Hospital ( Site 1404)

    Istanbul, Turkey (Türkiye) · Recruiting

  • Great Ormond Street Hospital For Children NHS Foundation Trust ( Site 1500)

    London, London, City of, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.